| scholarly article | Q13442814 |
| P2093 | author name string | Michel Rigaud | |
| Guislaine Barrière | |||
| Michel Tartary | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression | Q24633875 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Akt2: a role in breast cancer metastasis | Q24803933 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat | Q79271451 | ||
| The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression | Q82106573 | ||
| Circulating tumor cells: not all detected cells are bad and not all bad cells are detected | Q83663783 | ||
| Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer | Q83998770 | ||
| Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers | Q84772564 | ||
| Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells | Q85060184 | ||
| Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells | Q28609117 | ||
| Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
| Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature | Q29622952 | ||
| Epithelial to mesenchymal transition and breast cancer. | Q33627118 | ||
| Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines | Q33627158 | ||
| Mechanisms of the epithelial-mesenchymal transition by TGF-beta | Q33804105 | ||
| Understanding the benefit of metformin use in cancer treatment | Q33864199 | ||
| Phosphoinositide 3-kinase signalling pathways | Q33940898 | ||
| A positive role of cadherin in Wnt/β-catenin signalling during epithelial-mesenchymal transition | Q34016436 | ||
| Snail family regulation and epithelial mesenchymal transitions in breast cancer progression | Q34095480 | ||
| The role of the miR-200 family in epithelial-mesenchymal transition | Q34123520 | ||
| Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers | Q35169094 | ||
| Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy | Q35204595 | ||
| Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition | Q35558027 | ||
| Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. | Q35558093 | ||
| Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles | Q35608699 | ||
| A novel platform for detection of CK+ and CK- CTCs | Q35612329 | ||
| aV integrins and TGF-β-induced EMT: a circle of regulation | Q35791382 | ||
| Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis | Q36000472 | ||
| Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer | Q36934364 | ||
| Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery | Q37089909 | ||
| Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. | Q37090760 | ||
| Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. | Q37164129 | ||
| Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients | Q37360176 | ||
| E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer | Q37372547 | ||
| Circulating and disseminated tumor cells in the management of breast cancer | Q37552483 | ||
| Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. | Q37721840 | ||
| The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature | Q37839795 | ||
| Single-cell gene-expression profiling and its potential diagnostic applications | Q37929200 | ||
| Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer | Q39463407 | ||
| Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a | Q39582748 | ||
| Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status | Q39648560 | ||
| Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition | Q39659307 | ||
| Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells | Q39795883 | ||
| Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. | Q39822968 | ||
| Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype | Q40012189 | ||
| Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer | Q43041616 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 382010 | |
| P577 | publication date | 2012-04-11 | |
| P1433 | published in | ISRN Oncology | Q26842194 |
| P1476 | title | Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells | |
| P478 | volume | 2012 |
| Q37582197 | A circulating tumor cell cluster-based model for tumor metastasis (Hypothesis). |
| Q28072736 | Blood-based Tumor Markers in Lung Cancer |
| Q27024191 | Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research |
| Q35124176 | Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity |
| Q49843525 | Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood |
| Q38852105 | Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery |
| Q36689065 | EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low |
| Q41836514 | Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer |
| Q91753929 | Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases |
| Q34707177 | Implications of Mesenchymal Cells in Cancer Stem Cell Populations: Relevance to EMT. |
| Q35664886 | Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs |
| Q57821471 | Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition |
| Q87745740 | Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer |
| Q38693785 | Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks |
| Q38689543 | Retrospective Proteomic Screening of 100 Breast Cancer Tissues. |
| Q45970943 | SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis. |
| Q35347566 | Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells |
| Q52942284 | [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study]. |
Search more.